Cangene
Emergent BioSolutions is dedicated to developing and manufacturing innovative medical countermeasures and vaccines to protect against biological threats and public health emergencies. The company focuses on providing solutions for biodefense, infectious diseases, and opioid crisis response, with a mission to protect and enhance life.
Industries
Nr. of Employees
large (251-1000)
Cangene
Baltimore, Maryland, United States, North America
Products
Biodefense vaccines
Vaccines intended for protection against high-consequence pathogens used in public health preparedness and response.
Immune globulin therapeutics
Intravenous human immune globulin therapies for treatment of toxin or infectious agent exposures.
Antitoxin therapeutics
Antitoxin products, including equine‑derived formulations, for management of toxin-mediated conditions.
Antiviral therapeutics
Small-molecule antiviral therapeutics intended for treatment of viral infections relevant to public health response.
Opioid overdose rescue formulations (intranasal naloxone)
Intranasal opioid overdose reversal formulations intended for emergency use by healthcare providers, first responders, and the public.
Biodefense vaccines
Vaccines intended for protection against high-consequence pathogens used in public health preparedness and response.
Immune globulin therapeutics
Intravenous human immune globulin therapies for treatment of toxin or infectious agent exposures.
Antitoxin therapeutics
Antitoxin products, including equine‑derived formulations, for management of toxin-mediated conditions.
Antiviral therapeutics
Small-molecule antiviral therapeutics intended for treatment of viral infections relevant to public health response.
Opioid overdose rescue formulations (intranasal naloxone)
Intranasal opioid overdose reversal formulations intended for emergency use by healthcare providers, first responders, and the public.
Services
Medical information and pharmacovigilance support
Provision of medical information, adverse event reporting channels, and product complaint handling via phone, email, and web forms.
Product verification and DSCSA support
Support for serialized product verification, master data inquiries, and tracing requests to reduce counterfeiting and ensure supply chain security.
Expanded access (Individual Named Patient Use) processing
Intake and review pathway for healthcare providers to request access to products for individual patients when commercial options are not available.
Medical information and pharmacovigilance support
Provision of medical information, adverse event reporting channels, and product complaint handling via phone, email, and web forms.
Product verification and DSCSA support
Support for serialized product verification, master data inquiries, and tracing requests to reduce counterfeiting and ensure supply chain security.
Expanded access (Individual Named Patient Use) processing
Intake and review pathway for healthcare providers to request access to products for individual patients when commercial options are not available.
Expertise Areas
- Vaccine manufacturing and supply
- Biologics and antitoxin therapeutics
- Pharmacovigilance and medical information
- Regulatory compliance and DSCSA supply chain security
Key Technologies
- Vaccine production (including live and adjuvanted formulations)
- Plasma-derived immune globulin production
- Equine-derived antitoxin manufacturing
- Intranasal drug formulation (naloxone nasal spray)